nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—ORM1—Quinidine—malaria	0.0354	0.054	CbGbCtD
Imatinib—SLC22A2—Quinine—malaria	0.0333	0.0508	CbGbCtD
Imatinib—SLC22A2—Quinidine—malaria	0.0292	0.0446	CbGbCtD
Imatinib—SLC22A1—Quinine—malaria	0.0289	0.0441	CbGbCtD
Imatinib—SLC22A1—Quinidine—malaria	0.0254	0.0388	CbGbCtD
Imatinib—CYP3A5—Artemether—malaria	0.0225	0.0343	CbGbCtD
Imatinib—CYP3A7—Quinine—malaria	0.0181	0.0277	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Quinine—malaria	0.0181	0.0277	CbGbCtD
Imatinib—CYP2C19—Artemether—malaria	0.0181	0.0277	CbGbCtD
Imatinib—CYP3A4—Clindamycin—malaria	0.0179	0.0274	CbGbCtD
Imatinib—CYP2C9—Sulfadiazine—malaria	0.0177	0.027	CbGbCtD
Imatinib—CYP2C9—Pyrimethamine—malaria	0.0177	0.027	CbGbCtD
Imatinib—PTGS1—Dapsone—malaria	0.0172	0.0262	CbGbCtD
Imatinib—CYP2C19—Proguanil—malaria	0.017	0.026	CbGbCtD
Imatinib—CYP2D6—Pyrimethamine—malaria	0.0162	0.0247	CbGbCtD
Imatinib—CYP3A7—Quinidine—malaria	0.0159	0.0243	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Quinidine—malaria	0.0159	0.0243	CbGbCtD
Imatinib—CYP1A2—Proguanil—malaria	0.0157	0.024	CbGbCtD
Imatinib—CYP2C9—Artemether—malaria	0.0151	0.023	CbGbCtD
Imatinib—CYP2C9—Proguanil—malaria	0.0142	0.0216	CbGbCtD
Imatinib—CYP2D6—Artemether—malaria	0.0138	0.021	CbGbCtD
Imatinib—CYP3A7—Dapsone—malaria	0.0137	0.021	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Dapsone—malaria	0.0137	0.021	CbGbCtD
Imatinib—CYP3A5—Quinine—malaria	0.0136	0.0208	CbGbCtD
Imatinib—CYP2D6—Proguanil—malaria	0.0129	0.0198	CbGbCtD
Imatinib—CYP2D6—Quinidine barbiturate—malaria	0.0123	0.0187	CbGbCtD
Imatinib—CYP1A2—Pentoxifylline—malaria	0.0113	0.0172	CbGbCtD
Imatinib—CYP2C19—Quinine—malaria	0.011	0.0168	CbGbCtD
Imatinib—CYP3A5—Dapsone—malaria	0.0103	0.0157	CbGbCtD
Imatinib—CYP3A4—Sulfadiazine—malaria	0.0103	0.0157	CbGbCtD
Imatinib—CYP1A2—Quinine—malaria	0.0101	0.0155	CbGbCtD
Imatinib—CYP2C9—Quinine—malaria	0.00912	0.0139	CbGbCtD
Imatinib—CYP1A2—Quinidine—malaria	0.0089	0.0136	CbGbCtD
Imatinib—ABCB1—Quinine—malaria	0.00885	0.0135	CbGbCtD
Imatinib—CYP3A4—Artemether—malaria	0.00875	0.0134	CbGbCtD
Imatinib—CYP2D6—Quinine—malaria	0.00834	0.0127	CbGbCtD
Imatinib—CYP2C19—Dapsone—malaria	0.00832	0.0127	CbGbCtD
Imatinib—CYP3A4—Proguanil—malaria	0.00823	0.0126	CbGbCtD
Imatinib—CYP2C9—Quinidine—malaria	0.00802	0.0122	CbGbCtD
Imatinib—CYP3A4—Doxycycline—malaria	0.0078	0.0119	CbGbCtD
Imatinib—ABCB1—Quinidine—malaria	0.00778	0.0119	CbGbCtD
Imatinib—CYP2D6—Quinidine—malaria	0.00733	0.0112	CbGbCtD
Imatinib—CYP2C9—Dapsone—malaria	0.00691	0.0106	CbGbCtD
Imatinib—CA6—saliva—malaria	0.00539	0.0547	CbGeAlD
Imatinib—CYP3A4—Quinine—malaria	0.0053	0.0081	CbGbCtD
Imatinib—CYP3A4—Quinidine—malaria	0.00466	0.00712	CbGbCtD
Imatinib—CYP3A4—Dapsone—malaria	0.00402	0.00614	CbGbCtD
Imatinib—Ponatinib—KDR—malaria	0.00296	1	CrCbGaD
Imatinib—ORM1—saliva—malaria	0.00287	0.0291	CbGeAlD
Imatinib—ABCA3—saliva-secreting gland—malaria	0.00237	0.024	CbGeAlD
Imatinib—DDR1—saliva-secreting gland—malaria	0.00218	0.0222	CbGeAlD
Imatinib—KIT—endothelium—malaria	0.00153	0.0156	CbGeAlD
Imatinib—CSF1R—blood plasma—malaria	0.0015	0.0152	CbGeAlD
Imatinib—ABCA3—blood—malaria	0.0015	0.0152	CbGeAlD
Imatinib—DDR1—blood—malaria	0.00138	0.014	CbGeAlD
Imatinib—KIT—blood plasma—malaria	0.00136	0.0138	CbGeAlD
Imatinib—CA6—saliva-secreting gland—malaria	0.00136	0.0138	CbGeAlD
Imatinib—PIP4K2C—saliva-secreting gland—malaria	0.00135	0.0137	CbGeAlD
Imatinib—CA1—blood plasma—malaria	0.00125	0.0127	CbGeAlD
Imatinib—CA7—kidney—malaria	0.0011	0.0111	CbGeAlD
Imatinib—DDR1—liver—malaria	0.00108	0.011	CbGeAlD
Imatinib—NQO2—saliva-secreting gland—malaria	0.00099	0.0101	CbGeAlD
Imatinib—PDGFRA—hematopoietic system—malaria	0.000943	0.00957	CbGeAlD
Imatinib—HIPK4—brain—malaria	0.000939	0.00954	CbGeAlD
Imatinib—CA7—digestive system—malaria	0.000931	0.00946	CbGeAlD
Imatinib—ABCA3—brain—malaria	0.000929	0.00943	CbGeAlD
Imatinib—ABL2—blood—malaria	0.000901	0.00915	CbGeAlD
Imatinib—CYP2C19—blood plasma—malaria	0.000882	0.00895	CbGeAlD
Imatinib—DDR1—brain—malaria	0.000857	0.0087	CbGeAlD
Imatinib—PIP4K2C—blood—malaria	0.000852	0.00866	CbGeAlD
Imatinib—CSF1R—hematopoietic system—malaria	0.00083	0.00843	CbGeAlD
Imatinib—PIP4K2C—bone marrow—malaria	0.000825	0.00838	CbGeAlD
Imatinib—CA9—digestive system—malaria	0.000818	0.00831	CbGeAlD
Imatinib—CA2—blood plasma—malaria	0.000808	0.0082	CbGeAlD
Imatinib—KIT—saliva-secreting gland—malaria	0.00079	0.00802	CbGeAlD
Imatinib—CA3—bone marrow—malaria	0.000788	0.008	CbGeAlD
Imatinib—NQO2—kidney—malaria	0.000775	0.00787	CbGeAlD
Imatinib—PDGFRB—saliva-secreting gland—malaria	0.000771	0.00783	CbGeAlD
Imatinib—SLC47A1—hematopoietic system—malaria	0.000758	0.0077	CbGeAlD
Imatinib—LCK—blood—malaria	0.000757	0.00769	CbGeAlD
Imatinib—KIT—hematopoietic system—malaria	0.000754	0.00765	CbGeAlD
Imatinib—PDGFRB—hematopoietic system—malaria	0.000736	0.00748	CbGeAlD
Imatinib—SLC22A2—kidney—malaria	0.000734	0.00745	CbGeAlD
Imatinib—LCK—bone marrow—malaria	0.000732	0.00744	CbGeAlD
Imatinib—CYP1A2—blood plasma—malaria	0.00072	0.00731	CbGeAlD
Imatinib—CA12—kidney—malaria	0.000713	0.00724	CbGeAlD
Imatinib—ABL2—liver—malaria	0.000705	0.00716	CbGeAlD
Imatinib—PTGS1—endothelium—malaria	0.000703	0.00714	CbGeAlD
Imatinib—CYP3A5—blood plasma—malaria	0.000694	0.00705	CbGeAlD
Imatinib—ORM1—hematopoietic system—malaria	0.00069	0.00701	CbGeAlD
Imatinib—CA1—hematopoietic system—malaria	0.000689	0.007	CbGeAlD
Imatinib—ABL1—saliva-secreting gland—malaria	0.000687	0.00698	CbGeAlD
Imatinib—CYP2C9—blood plasma—malaria	0.000683	0.00694	CbGeAlD
Imatinib—PIP4K2C—liver—malaria	0.000667	0.00677	CbGeAlD
Imatinib—ABL1—hematopoietic system—malaria	0.000656	0.00666	CbGeAlD
Imatinib—PDGFRA—digestive system—malaria	0.000655	0.00666	CbGeAlD
Imatinib—CA3—liver—malaria	0.000636	0.00646	CbGeAlD
Imatinib—NQO2—blood—malaria	0.000626	0.00636	CbGeAlD
Imatinib—PDGFRA—blood—malaria	0.000624	0.00634	CbGeAlD
Imatinib—PTGS1—blood plasma—malaria	0.000624	0.00634	CbGeAlD
Imatinib—SLC22A2—digestive system—malaria	0.000623	0.00632	CbGeAlD
Imatinib—SLC47A1—kidney—malaria	0.000621	0.00631	CbGeAlD
Imatinib—KIT—kidney—malaria	0.000618	0.00627	CbGeAlD
Imatinib—NQO2—bone marrow—malaria	0.000606	0.00615	CbGeAlD
Imatinib—CA12—digestive system—malaria	0.000605	0.00614	CbGeAlD
Imatinib—PDGFRB—kidney—malaria	0.000603	0.00613	CbGeAlD
Imatinib—LCK—liver—malaria	0.000592	0.00601	CbGeAlD
Imatinib—CA14—liver—malaria	0.000578	0.00587	CbGeAlD
Imatinib—CSF1R—digestive system—malaria	0.000577	0.00586	CbGeAlD
Imatinib—CYP3A7—liver—malaria	0.000565	0.00574	CbGeAlD
Imatinib—CA1—kidney—malaria	0.000565	0.00574	CbGeAlD
Imatinib—ABL2—brain—malaria	0.000559	0.00568	CbGeAlD
Imatinib—CA7—brain—malaria	0.000551	0.00559	CbGeAlD
Imatinib—CSF1R—blood—malaria	0.00055	0.00558	CbGeAlD
Imatinib—ABL1—kidney—malaria	0.000538	0.00546	CbGeAlD
Imatinib—CSF1R—bone marrow—malaria	0.000532	0.0054	CbGeAlD
Imatinib—PIP4K2C—brain—malaria	0.000529	0.00537	CbGeAlD
Imatinib—SLC47A1—digestive system—malaria	0.000527	0.00535	CbGeAlD
Imatinib—KIT—digestive system—malaria	0.000524	0.00532	CbGeAlD
Imatinib—CYP3A4—blood plasma—malaria	0.000521	0.00529	CbGeAlD
Imatinib—SLC22A1—kidney—malaria	0.000518	0.00526	CbGeAlD
Imatinib—CYP2D6—blood plasma—malaria	0.000513	0.00521	CbGeAlD
Imatinib—PDGFRB—digestive system—malaria	0.000512	0.0052	CbGeAlD
Imatinib—CA3—brain—malaria	0.000505	0.00513	CbGeAlD
Imatinib—SLC47A1—blood—malaria	0.000502	0.0051	CbGeAlD
Imatinib—KIT—blood—malaria	0.000499	0.00507	CbGeAlD
Imatinib—NQO2—liver—malaria	0.00049	0.00497	CbGeAlD
Imatinib—PDGFRA—liver—malaria	0.000488	0.00496	CbGeAlD
Imatinib—PDGFRB—blood—malaria	0.000488	0.00495	CbGeAlD
Imatinib—CYP2C19—hematopoietic system—malaria	0.000487	0.00495	CbGeAlD
Imatinib—KIT—bone marrow—malaria	0.000483	0.00491	CbGeAlD
Imatinib—CYP3A7-CYP3A51P—liver—malaria	0.000481	0.00488	CbGeAlD
Imatinib—CA1—digestive system—malaria	0.000479	0.00487	CbGeAlD
Imatinib—PDGFRB—bone marrow—malaria	0.000472	0.00479	CbGeAlD
Imatinib—CA2—saliva-secreting gland—malaria	0.000468	0.00475	CbGeAlD
Imatinib—CA14—brain—malaria	0.000459	0.00466	CbGeAlD
Imatinib—ORM1—blood—malaria	0.000457	0.00465	CbGeAlD
Imatinib—CA1—blood—malaria	0.000457	0.00464	CbGeAlD
Imatinib—ABL1—digestive system—malaria	0.000456	0.00463	CbGeAlD
Imatinib—CA2—hematopoietic system—malaria	0.000447	0.00454	CbGeAlD
Imatinib—ORM1—bone marrow—malaria	0.000443	0.0045	CbGeAlD
Imatinib—CA1—bone marrow—malaria	0.000442	0.00449	CbGeAlD
Imatinib—ABL1—blood—malaria	0.000435	0.00441	CbGeAlD
Imatinib—ABCG2—saliva-secreting gland—malaria	0.000433	0.0044	CbGeAlD
Imatinib—CSF1R—liver—malaria	0.00043	0.00437	CbGeAlD
Imatinib—ABL1—bone marrow—malaria	0.000421	0.00427	CbGeAlD
Imatinib—SLC22A1—blood—malaria	0.000419	0.00426	CbGeAlD
Imatinib—CYP1A2—hematopoietic system—malaria	0.000398	0.00404	CbGeAlD
Imatinib—SLC47A1—liver—malaria	0.000393	0.00399	CbGeAlD
Imatinib—KIT—liver—malaria	0.00039	0.00397	CbGeAlD
Imatinib—NQO2—brain—malaria	0.000388	0.00395	CbGeAlD
Imatinib—PDGFRA—brain—malaria	0.000387	0.00394	CbGeAlD
Imatinib—CYP3A5—hematopoietic system—malaria	0.000384	0.0039	CbGeAlD
Imatinib—PDGFRB—liver—malaria	0.000381	0.00387	CbGeAlD
Imatinib—CYP2C9—hematopoietic system—malaria	0.000378	0.00384	CbGeAlD
Imatinib—ABCB1—blood plasma—malaria	0.000369	0.00375	CbGeAlD
Imatinib—CA2—kidney—malaria	0.000366	0.00372	CbGeAlD
Imatinib—ORM1—liver—malaria	0.000358	0.00363	CbGeAlD
Imatinib—CA12—brain—malaria	0.000358	0.00363	CbGeAlD
Imatinib—CA1—liver—malaria	0.000357	0.00363	CbGeAlD
Imatinib—PTGS1—hematopoietic system—malaria	0.000345	0.0035	CbGeAlD
Imatinib—CSF1R—brain—malaria	0.000341	0.00347	CbGeAlD
Imatinib—ABL1—liver—malaria	0.00034	0.00345	CbGeAlD
Imatinib—CYP2C19—digestive system—malaria	0.000339	0.00344	CbGeAlD
Imatinib—SLC22A1—liver—malaria	0.000328	0.00333	CbGeAlD
Imatinib—CYP2C19—blood—malaria	0.000323	0.00328	CbGeAlD
Imatinib—CYP3A5—kidney—malaria	0.000315	0.0032	CbGeAlD
Imatinib—ALB—liver—malaria	0.000314	0.00319	CbGeAlD
Imatinib—SLC47A1—brain—malaria	0.000312	0.00316	CbGeAlD
Imatinib—CA2—digestive system—malaria	0.000311	0.00316	CbGeAlD
Imatinib—KIT—brain—malaria	0.00031	0.00315	CbGeAlD
Imatinib—PDGFRB—brain—malaria	0.000303	0.00307	CbGeAlD
Imatinib—CA2—blood—malaria	0.000296	0.00301	CbGeAlD
Imatinib—CYP3A4—hematopoietic system—malaria	0.000288	0.00293	CbGeAlD
Imatinib—CA2—bone marrow—malaria	0.000286	0.00291	CbGeAlD
Imatinib—CYP2D6—hematopoietic system—malaria	0.000284	0.00288	CbGeAlD
Imatinib—CA1—brain—malaria	0.000283	0.00288	CbGeAlD
Imatinib—PTGS1—kidney—malaria	0.000283	0.00287	CbGeAlD
Imatinib—CYP1A2—digestive system—malaria	0.000277	0.00281	CbGeAlD
Imatinib—ABCG2—blood—malaria	0.000274	0.00278	CbGeAlD
Imatinib—ABL1—brain—malaria	0.00027	0.00274	CbGeAlD
Imatinib—CYP3A5—digestive system—malaria	0.000267	0.00271	CbGeAlD
Imatinib—ABCG2—bone marrow—malaria	0.000265	0.00269	CbGeAlD
Imatinib—CYP1A2—blood—malaria	0.000264	0.00268	CbGeAlD
Imatinib—CYP2C9—digestive system—malaria	0.000263	0.00267	CbGeAlD
Imatinib—SLC22A1—brain—malaria	0.00026	0.00264	CbGeAlD
Imatinib—CYP3A5—blood—malaria	0.000254	0.00258	CbGeAlD
Imatinib—CYP2C19—liver—malaria	0.000253	0.00256	CbGeAlD
Imatinib—CYP2C9—blood—malaria	0.00025	0.00254	CbGeAlD
Imatinib—ALB—brain—malaria	0.000249	0.00253	CbGeAlD
Imatinib—PTGS1—digestive system—malaria	0.00024	0.00244	CbGeAlD
Imatinib—CYP3A4—kidney—malaria	0.000236	0.0024	CbGeAlD
Imatinib—Back pain—Clindamycin—malaria	0.000234	0.00136	CcSEcCtD
Imatinib—CYP2D6—kidney—malaria	0.000232	0.00236	CbGeAlD
Imatinib—Erythema multiforme—Quinidine barbiturate—malaria	0.000232	0.00135	CcSEcCtD
Imatinib—Muscle spasms—Clindamycin—malaria	0.000232	0.00135	CcSEcCtD
Imatinib—CA2—liver—malaria	0.000231	0.00235	CbGeAlD
Imatinib—Decreased appetite—Sulfadiazine—malaria	0.00023	0.00134	CcSEcCtD
Imatinib—Eye disorder—Quinidine barbiturate—malaria	0.000229	0.00133	CcSEcCtD
Imatinib—Tinnitus—Quinidine barbiturate—malaria	0.000229	0.00133	CcSEcCtD
Imatinib—PTGS1—blood—malaria	0.000229	0.00232	CbGeAlD
Imatinib—Gastrointestinal disorder—Sulfadiazine—malaria	0.000228	0.00133	CcSEcCtD
Imatinib—Flushing—Quinidine barbiturate—malaria	0.000228	0.00133	CcSEcCtD
Imatinib—Cardiac disorder—Quinidine barbiturate—malaria	0.000228	0.00133	CcSEcCtD
Imatinib—Flushing—Pentoxifylline—malaria	0.000227	0.00132	CcSEcCtD
Imatinib—Vertigo—Dapsone—malaria	0.000224	0.0013	CcSEcCtD
Imatinib—Vision blurred—Quinidine—malaria	0.000223	0.0013	CcSEcCtD
Imatinib—Vision blurred—Quinine—malaria	0.000223	0.0013	CcSEcCtD
Imatinib—Anaemia—Clindamycin—malaria	0.000223	0.0013	CcSEcCtD
Imatinib—Tremor—Quinidine—malaria	0.000222	0.00129	CcSEcCtD
Imatinib—Tremor—Quinine—malaria	0.000222	0.00129	CcSEcCtD
Imatinib—Immune system disorder—Quinidine barbiturate—malaria	0.000222	0.00129	CcSEcCtD
Imatinib—Immune system disorder—Pentoxifylline—malaria	0.000221	0.00129	CcSEcCtD
Imatinib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000221	0.00129	CcSEcCtD
Imatinib—Chills—Quinidine barbiturate—malaria	0.00022	0.00128	CcSEcCtD
Imatinib—Arrhythmia—Pentoxifylline—malaria	0.000219	0.00127	CcSEcCtD
Imatinib—Cough—Dapsone—malaria	0.000218	0.00127	CcSEcCtD
Imatinib—Vertigo—Clindamycin—malaria	0.000217	0.00126	CcSEcCtD
Imatinib—Angioedema—Quinine—malaria	0.000216	0.00126	CcSEcCtD
Imatinib—Angioedema—Quinidine—malaria	0.000216	0.00126	CcSEcCtD
Imatinib—Gastrointestinal pain—Sulfadiazine—malaria	0.000216	0.00126	CcSEcCtD
Imatinib—Leukopenia—Clindamycin—malaria	0.000216	0.00126	CcSEcCtD
Imatinib—Mental disorder—Quinidine barbiturate—malaria	0.000215	0.00125	CcSEcCtD
Imatinib—ABCG2—liver—malaria	0.000214	0.00218	CbGeAlD
Imatinib—Erythema—Quinidine barbiturate—malaria	0.000214	0.00124	CcSEcCtD
Imatinib—Malnutrition—Quinidine barbiturate—malaria	0.000214	0.00124	CcSEcCtD
Imatinib—Erythema—Pentoxifylline—malaria	0.000213	0.00124	CcSEcCtD
Imatinib—Vertigo—Quinine—malaria	0.000213	0.00124	CcSEcCtD
Imatinib—Vertigo—Quinidine—malaria	0.000213	0.00124	CcSEcCtD
Imatinib—Syncope—Quinine—malaria	0.000212	0.00124	CcSEcCtD
Imatinib—Syncope—Quinidine—malaria	0.000212	0.00124	CcSEcCtD
Imatinib—Leukopenia—Quinine—malaria	0.000212	0.00123	CcSEcCtD
Imatinib—Leukopenia—Quinidine—malaria	0.000212	0.00123	CcSEcCtD
Imatinib—Flatulence—Pentoxifylline—malaria	0.00021	0.00122	CcSEcCtD
Imatinib—Urticaria—Sulfadiazine—malaria	0.00021	0.00122	CcSEcCtD
Imatinib—Palpitations—Quinine—malaria	0.000209	0.00122	CcSEcCtD
Imatinib—Palpitations—Quinidine—malaria	0.000209	0.00122	CcSEcCtD
Imatinib—Abdominal pain—Sulfadiazine—malaria	0.000209	0.00122	CcSEcCtD
Imatinib—Body temperature increased—Sulfadiazine—malaria	0.000209	0.00122	CcSEcCtD
Imatinib—Dysgeusia—Pentoxifylline—malaria	0.000209	0.00122	CcSEcCtD
Imatinib—Hypertension—Clindamycin—malaria	0.000208	0.00121	CcSEcCtD
Imatinib—Loss of consciousness—Quinidine—malaria	0.000208	0.00121	CcSEcCtD
Imatinib—Loss of consciousness—Quinine—malaria	0.000208	0.00121	CcSEcCtD
Imatinib—Back pain—Pentoxifylline—malaria	0.000206	0.0012	CcSEcCtD
Imatinib—CYP1A2—liver—malaria	0.000206	0.00209	CbGeAlD
Imatinib—Convulsion—Quinidine—malaria	0.000205	0.00119	CcSEcCtD
Imatinib—Convulsion—Quinine—malaria	0.000205	0.00119	CcSEcCtD
Imatinib—Muscle spasms—Pentoxifylline—malaria	0.000205	0.00119	CcSEcCtD
Imatinib—ABCB1—hematopoietic system—malaria	0.000204	0.00207	CbGeAlD
Imatinib—Discomfort—Clindamycin—malaria	0.000203	0.00118	CcSEcCtD
Imatinib—Chest pain—Quinidine—malaria	0.000202	0.00117	CcSEcCtD
Imatinib—Myalgia—Quinine—malaria	0.000202	0.00117	CcSEcCtD
Imatinib—Myalgia—Quinidine—malaria	0.000202	0.00117	CcSEcCtD
Imatinib—Chest pain—Quinine—malaria	0.000202	0.00117	CcSEcCtD
Imatinib—Vision blurred—Quinidine barbiturate—malaria	0.000201	0.00117	CcSEcCtD
Imatinib—Vision blurred—Pentoxifylline—malaria	0.000201	0.00117	CcSEcCtD
Imatinib—CYP3A4—digestive system—malaria	0.0002	0.00204	CbGeAlD
Imatinib—Tremor—Quinidine barbiturate—malaria	0.0002	0.00117	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.0002	0.00116	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.0002	0.00116	CcSEcCtD
Imatinib—Tremor—Pentoxifylline—malaria	0.0002	0.00116	CcSEcCtD
Imatinib—CYP3A5—liver—malaria	0.000199	0.00202	CbGeAlD
Imatinib—Tachycardia—Dapsone—malaria	0.000199	0.00116	CcSEcCtD
Imatinib—Ill-defined disorder—Pentoxifylline—malaria	0.000198	0.00115	CcSEcCtD
Imatinib—CYP2D6—digestive system—malaria	0.000197	0.002	CbGeAlD
Imatinib—Anaemia—Pentoxifylline—malaria	0.000197	0.00115	CcSEcCtD
Imatinib—Anaphylactic shock—Clindamycin—malaria	0.000197	0.00115	CcSEcCtD
Imatinib—CYP2C9—liver—malaria	0.000196	0.00199	CbGeAlD
Imatinib—Angioedema—Quinidine barbiturate—malaria	0.000195	0.00114	CcSEcCtD
Imatinib—Angioedema—Pentoxifylline—malaria	0.000195	0.00113	CcSEcCtD
Imatinib—Hypersensitivity—Sulfadiazine—malaria	0.000195	0.00113	CcSEcCtD
Imatinib—Confusional state—Quinine—malaria	0.000195	0.00113	CcSEcCtD
Imatinib—Confusional state—Quinidine—malaria	0.000195	0.00113	CcSEcCtD
Imatinib—Oedema—Quinine—malaria	0.000193	0.00112	CcSEcCtD
Imatinib—Oedema—Quinidine—malaria	0.000193	0.00112	CcSEcCtD
Imatinib—Thrombocytopenia—Clindamycin—malaria	0.000193	0.00112	CcSEcCtD
Imatinib—Malaise—Pentoxifylline—malaria	0.000192	0.00112	CcSEcCtD
Imatinib—Vertigo—Quinidine barbiturate—malaria	0.000192	0.00112	CcSEcCtD
Imatinib—Syncope—Quinidine barbiturate—malaria	0.000192	0.00112	CcSEcCtD
Imatinib—Leukopenia—Quinidine barbiturate—malaria	0.000191	0.00111	CcSEcCtD
Imatinib—Leukopenia—Pentoxifylline—malaria	0.000191	0.00111	CcSEcCtD
Imatinib—CYP3A4—blood—malaria	0.000191	0.00194	CbGeAlD
Imatinib—Shock—Quinine—malaria	0.00019	0.00111	CcSEcCtD
Imatinib—Shock—Quinidine—malaria	0.00019	0.00111	CcSEcCtD
Imatinib—Nervous system disorder—Quinine—malaria	0.00019	0.0011	CcSEcCtD
Imatinib—Nervous system disorder—Quinidine—malaria	0.00019	0.0011	CcSEcCtD
Imatinib—Thrombocytopenia—Quinidine—malaria	0.000189	0.0011	CcSEcCtD
Imatinib—Thrombocytopenia—Quinine—malaria	0.000189	0.0011	CcSEcCtD
Imatinib—Palpitations—Quinidine barbiturate—malaria	0.000189	0.0011	CcSEcCtD
Imatinib—Tachycardia—Quinidine—malaria	0.000189	0.0011	CcSEcCtD
Imatinib—Tachycardia—Quinine—malaria	0.000189	0.0011	CcSEcCtD
Imatinib—Palpitations—Pentoxifylline—malaria	0.000189	0.0011	CcSEcCtD
Imatinib—CYP2D6—blood—malaria	0.000188	0.00191	CbGeAlD
Imatinib—Loss of consciousness—Quinidine barbiturate—malaria	0.000188	0.00109	CcSEcCtD
Imatinib—Skin disorder—Quinidine—malaria	0.000188	0.00109	CcSEcCtD
Imatinib—Skin disorder—Quinine—malaria	0.000188	0.00109	CcSEcCtD
Imatinib—Pruritus—Sulfadiazine—malaria	0.000187	0.00109	CcSEcCtD
Imatinib—Hyperhidrosis—Quinidine—malaria	0.000187	0.00109	CcSEcCtD
Imatinib—Hyperhidrosis—Quinine—malaria	0.000187	0.00109	CcSEcCtD
Imatinib—Convulsion—Quinidine barbiturate—malaria	0.000185	0.00108	CcSEcCtD
Imatinib—Convulsion—Pentoxifylline—malaria	0.000185	0.00108	CcSEcCtD
Imatinib—Anorexia—Quinine—malaria	0.000184	0.00107	CcSEcCtD
Imatinib—Anorexia—Quinidine—malaria	0.000184	0.00107	CcSEcCtD
Imatinib—Insomnia—Dapsone—malaria	0.000184	0.00107	CcSEcCtD
Imatinib—Hypertension—Pentoxifylline—malaria	0.000184	0.00107	CcSEcCtD
Imatinib—Hypotension—Clindamycin—malaria	0.000184	0.00107	CcSEcCtD
Imatinib—CA2—brain—malaria	0.000184	0.00187	CbGeAlD
Imatinib—Myalgia—Quinidine barbiturate—malaria	0.000182	0.00106	CcSEcCtD
Imatinib—Arthralgia—Quinidine barbiturate—malaria	0.000182	0.00106	CcSEcCtD
Imatinib—Chest pain—Quinidine barbiturate—malaria	0.000182	0.00106	CcSEcCtD
Imatinib—Chest pain—Pentoxifylline—malaria	0.000182	0.00106	CcSEcCtD
Imatinib—Myalgia—Pentoxifylline—malaria	0.000182	0.00106	CcSEcCtD
Imatinib—Anxiety—Quinidine barbiturate—malaria	0.000181	0.00106	CcSEcCtD
Imatinib—Diarrhoea—Sulfadiazine—malaria	0.000181	0.00105	CcSEcCtD
Imatinib—Anxiety—Pentoxifylline—malaria	0.000181	0.00105	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000181	0.00105	CcSEcCtD
Imatinib—Hypotension—Quinidine—malaria	0.000181	0.00105	CcSEcCtD
Imatinib—Hypotension—Quinine—malaria	0.000181	0.00105	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00018	0.00105	CcSEcCtD
Imatinib—Discomfort—Pentoxifylline—malaria	0.000179	0.00104	CcSEcCtD
Imatinib—Dry mouth—Pentoxifylline—malaria	0.000178	0.00103	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Quinidine—malaria	0.000176	0.00102	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Quinine—malaria	0.000176	0.00102	CcSEcCtD
Imatinib—Confusional state—Quinidine barbiturate—malaria	0.000176	0.00102	CcSEcCtD
Imatinib—Dyspnoea—Clindamycin—malaria	0.000176	0.00102	CcSEcCtD
Imatinib—Confusional state—Pentoxifylline—malaria	0.000176	0.00102	CcSEcCtD
Imatinib—Oedema—Quinidine barbiturate—malaria	0.000174	0.00101	CcSEcCtD
Imatinib—Anaphylactic shock—Pentoxifylline—malaria	0.000174	0.00101	CcSEcCtD
Imatinib—Oedema—Pentoxifylline—malaria	0.000174	0.00101	CcSEcCtD
Imatinib—Dyspepsia—Clindamycin—malaria	0.000173	0.00101	CcSEcCtD
Imatinib—Infection—Pentoxifylline—malaria	0.000173	0.00101	CcSEcCtD
Imatinib—Dyspnoea—Quinine—malaria	0.000172	0.001	CcSEcCtD
Imatinib—Dyspnoea—Quinidine—malaria	0.000172	0.001	CcSEcCtD
Imatinib—Shock—Quinidine barbiturate—malaria	0.000172	0.000998	CcSEcCtD
Imatinib—Shock—Pentoxifylline—malaria	0.000171	0.000997	CcSEcCtD
Imatinib—Nervous system disorder—Quinidine barbiturate—malaria	0.000171	0.000995	CcSEcCtD
Imatinib—Thrombocytopenia—Quinidine barbiturate—malaria	0.000171	0.000994	CcSEcCtD
Imatinib—Thrombocytopenia—Pentoxifylline—malaria	0.00017	0.000992	CcSEcCtD
Imatinib—Tachycardia—Quinidine barbiturate—malaria	0.00017	0.000991	CcSEcCtD
Imatinib—Gastrointestinal disorder—Clindamycin—malaria	0.00017	0.00099	CcSEcCtD
Imatinib—ABCG2—brain—malaria	0.00017	0.00173	CbGeAlD
Imatinib—Tachycardia—Pentoxifylline—malaria	0.00017	0.000989	CcSEcCtD
Imatinib—Fatigue—Clindamycin—malaria	0.00017	0.000988	CcSEcCtD
Imatinib—Skin disorder—Quinidine barbiturate—malaria	0.000169	0.000986	CcSEcCtD
Imatinib—Skin disorder—Pentoxifylline—malaria	0.000169	0.000984	CcSEcCtD
Imatinib—Hyperhidrosis—Quinidine barbiturate—malaria	0.000169	0.000981	CcSEcCtD
Imatinib—Pain—Clindamycin—malaria	0.000168	0.00098	CcSEcCtD
Imatinib—Constipation—Clindamycin—malaria	0.000168	0.00098	CcSEcCtD
Imatinib—Hyperhidrosis—Pentoxifylline—malaria	0.000168	0.000979	CcSEcCtD
Imatinib—Vomiting—Sulfadiazine—malaria	0.000168	0.000979	CcSEcCtD
Imatinib—Decreased appetite—Quinidine—malaria	0.000168	0.000978	CcSEcCtD
Imatinib—Decreased appetite—Quinine—malaria	0.000168	0.000978	CcSEcCtD
Imatinib—ABCB1—kidney—malaria	0.000167	0.0017	CbGeAlD
Imatinib—Gastrointestinal disorder—Quinine—malaria	0.000167	0.000971	CcSEcCtD
Imatinib—Gastrointestinal disorder—Quinidine—malaria	0.000167	0.000971	CcSEcCtD
Imatinib—Rash—Sulfadiazine—malaria	0.000167	0.000971	CcSEcCtD
Imatinib—Dermatitis—Sulfadiazine—malaria	0.000167	0.00097	CcSEcCtD
Imatinib—Gastrointestinal pain—Dapsone—malaria	0.000167	0.000969	CcSEcCtD
Imatinib—Anorexia—Quinidine barbiturate—malaria	0.000166	0.000967	CcSEcCtD
Imatinib—Anorexia—Pentoxifylline—malaria	0.000166	0.000966	CcSEcCtD
Imatinib—Headache—Sulfadiazine—malaria	0.000166	0.000964	CcSEcCtD
Imatinib—Hypotension—Quinidine barbiturate—malaria	0.000163	0.000948	CcSEcCtD
Imatinib—Hypotension—Pentoxifylline—malaria	0.000163	0.000947	CcSEcCtD
Imatinib—Gastrointestinal pain—Clindamycin—malaria	0.000161	0.000937	CcSEcCtD
Imatinib—Abdominal pain—Dapsone—malaria	0.000161	0.000937	CcSEcCtD
Imatinib—Body temperature increased—Dapsone—malaria	0.000161	0.000937	CcSEcCtD
Imatinib—Feeling abnormal—Quinine—malaria	0.000159	0.000927	CcSEcCtD
Imatinib—Feeling abnormal—Quinidine—malaria	0.000159	0.000927	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000159	0.000925	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000159	0.000923	CcSEcCtD
Imatinib—Gastrointestinal pain—Quinine—malaria	0.000158	0.00092	CcSEcCtD
Imatinib—Gastrointestinal pain—Quinidine—malaria	0.000158	0.00092	CcSEcCtD
Imatinib—Insomnia—Pentoxifylline—malaria	0.000157	0.000916	CcSEcCtD
Imatinib—Nausea—Sulfadiazine—malaria	0.000157	0.000914	CcSEcCtD
Imatinib—Urticaria—Clindamycin—malaria	0.000157	0.000911	CcSEcCtD
Imatinib—Abdominal pain—Clindamycin—malaria	0.000156	0.000906	CcSEcCtD
Imatinib—Body temperature increased—Clindamycin—malaria	0.000156	0.000906	CcSEcCtD
Imatinib—Dyspnoea—Quinidine barbiturate—malaria	0.000156	0.000905	CcSEcCtD
Imatinib—Dyspnoea—Pentoxifylline—malaria	0.000155	0.000903	CcSEcCtD
Imatinib—Somnolence—Quinidine barbiturate—malaria	0.000155	0.000902	CcSEcCtD
Imatinib—Somnolence—Pentoxifylline—malaria	0.000155	0.000901	CcSEcCtD
Imatinib—Urticaria—Quinidine—malaria	0.000154	0.000893	CcSEcCtD
Imatinib—Urticaria—Quinine—malaria	0.000154	0.000893	CcSEcCtD
Imatinib—Dyspepsia—Pentoxifylline—malaria	0.000153	0.000892	CcSEcCtD
Imatinib—Abdominal pain—Quinine—malaria	0.000153	0.000889	CcSEcCtD
Imatinib—Abdominal pain—Quinidine—malaria	0.000153	0.000889	CcSEcCtD
Imatinib—Body temperature increased—Quinidine—malaria	0.000153	0.000889	CcSEcCtD
Imatinib—Body temperature increased—Quinine—malaria	0.000153	0.000889	CcSEcCtD
Imatinib—Decreased appetite—Quinidine barbiturate—malaria	0.000152	0.000882	CcSEcCtD
Imatinib—Decreased appetite—Pentoxifylline—malaria	0.000151	0.000881	CcSEcCtD
Imatinib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000151	0.000876	CcSEcCtD
Imatinib—CYP3A4—liver—malaria	0.000149	0.00152	CbGeAlD
Imatinib—Constipation—Quinidine barbiturate—malaria	0.000149	0.000868	CcSEcCtD
Imatinib—Pain—Quinidine barbiturate—malaria	0.000149	0.000868	CcSEcCtD
Imatinib—Constipation—Pentoxifylline—malaria	0.000149	0.000866	CcSEcCtD
Imatinib—CYP2D6—liver—malaria	0.000147	0.00149	CbGeAlD
Imatinib—Hypersensitivity—Clindamycin—malaria	0.000145	0.000845	CcSEcCtD
Imatinib—Feeling abnormal—Quinidine barbiturate—malaria	0.000144	0.000836	CcSEcCtD
Imatinib—Feeling abnormal—Pentoxifylline—malaria	0.000143	0.000835	CcSEcCtD
Imatinib—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000143	0.00083	CcSEcCtD
Imatinib—Hypersensitivity—Quinidine—malaria	0.000142	0.000829	CcSEcCtD
Imatinib—Hypersensitivity—Quinine—malaria	0.000142	0.000829	CcSEcCtD
Imatinib—Gastrointestinal pain—Pentoxifylline—malaria	0.000142	0.000828	CcSEcCtD
Imatinib—ABCB1—digestive system—malaria	0.000142	0.00144	CbGeAlD
Imatinib—PTGS1—brain—malaria	0.000142	0.00144	CbGeAlD
Imatinib—Asthenia—Clindamycin—malaria	0.000141	0.000822	CcSEcCtD
Imatinib—Pruritus—Clindamycin—malaria	0.000139	0.000811	CcSEcCtD
Imatinib—Asthenia—Quinidine—malaria	0.000139	0.000807	CcSEcCtD
Imatinib—Asthenia—Quinine—malaria	0.000139	0.000807	CcSEcCtD
Imatinib—Urticaria—Quinidine barbiturate—malaria	0.000139	0.000806	CcSEcCtD
Imatinib—Urticaria—Pentoxifylline—malaria	0.000138	0.000805	CcSEcCtD
Imatinib—Abdominal pain—Quinidine barbiturate—malaria	0.000138	0.000802	CcSEcCtD
Imatinib—Body temperature increased—Quinidine barbiturate—malaria	0.000138	0.000802	CcSEcCtD
Imatinib—Body temperature increased—Pentoxifylline—malaria	0.000138	0.000801	CcSEcCtD
Imatinib—Abdominal pain—Pentoxifylline—malaria	0.000138	0.000801	CcSEcCtD
Imatinib—Pruritus—Quinidine—malaria	0.000137	0.000796	CcSEcCtD
Imatinib—Pruritus—Quinine—malaria	0.000137	0.000796	CcSEcCtD
Imatinib—ABCB1—blood—malaria	0.000135	0.00137	CbGeAlD
Imatinib—Diarrhoea—Clindamycin—malaria	0.000135	0.000784	CcSEcCtD
Imatinib—Diarrhoea—Quinidine—malaria	0.000132	0.000769	CcSEcCtD
Imatinib—Diarrhoea—Quinine—malaria	0.000132	0.000769	CcSEcCtD
Imatinib—ABCB1—bone marrow—malaria	0.000131	0.00133	CbGeAlD
Imatinib—Dizziness—Clindamycin—malaria	0.00013	0.000758	CcSEcCtD
Imatinib—Vomiting—Dapsone—malaria	0.000129	0.000753	CcSEcCtD
Imatinib—Hypersensitivity—Quinidine barbiturate—malaria	0.000129	0.000748	CcSEcCtD
Imatinib—Hypersensitivity—Pentoxifylline—malaria	0.000128	0.000746	CcSEcCtD
Imatinib—Dizziness—Quinine—malaria	0.000128	0.000744	CcSEcCtD
Imatinib—Dizziness—Quinidine—malaria	0.000128	0.000744	CcSEcCtD
Imatinib—Headache—Dapsone—malaria	0.000128	0.000742	CcSEcCtD
Imatinib—Vomiting—Clindamycin—malaria	0.000125	0.000729	CcSEcCtD
Imatinib—Asthenia—Quinidine barbiturate—malaria	0.000125	0.000728	CcSEcCtD
Imatinib—Asthenia—Pentoxifylline—malaria	0.000125	0.000727	CcSEcCtD
Imatinib—Rash—Clindamycin—malaria	0.000124	0.000723	CcSEcCtD
Imatinib—Dermatitis—Clindamycin—malaria	0.000124	0.000722	CcSEcCtD
Imatinib—Headache—Clindamycin—malaria	0.000123	0.000718	CcSEcCtD
Imatinib—Pruritus—Quinidine barbiturate—malaria	0.000123	0.000718	CcSEcCtD
Imatinib—Pruritus—Pentoxifylline—malaria	0.000123	0.000717	CcSEcCtD
Imatinib—Vomiting—Quinine—malaria	0.000123	0.000715	CcSEcCtD
Imatinib—Vomiting—Quinidine—malaria	0.000123	0.000715	CcSEcCtD
Imatinib—Rash—Quinidine—malaria	0.000122	0.000709	CcSEcCtD
Imatinib—Rash—Quinine—malaria	0.000122	0.000709	CcSEcCtD
Imatinib—Dermatitis—Quinine—malaria	0.000122	0.000708	CcSEcCtD
Imatinib—Dermatitis—Quinidine—malaria	0.000122	0.000708	CcSEcCtD
Imatinib—Headache—Quinidine—malaria	0.000121	0.000704	CcSEcCtD
Imatinib—Headache—Quinine—malaria	0.000121	0.000704	CcSEcCtD
Imatinib—Nausea—Dapsone—malaria	0.000121	0.000704	CcSEcCtD
Imatinib—Diarrhoea—Quinidine barbiturate—malaria	0.000119	0.000694	CcSEcCtD
Imatinib—Diarrhoea—Pentoxifylline—malaria	0.000119	0.000693	CcSEcCtD
Imatinib—Nausea—Clindamycin—malaria	0.000117	0.000681	CcSEcCtD
Imatinib—CYP2D6—brain—malaria	0.000117	0.00118	CbGeAlD
Imatinib—Dizziness—Quinidine barbiturate—malaria	0.000115	0.000671	CcSEcCtD
Imatinib—Dizziness—Pentoxifylline—malaria	0.000115	0.00067	CcSEcCtD
Imatinib—Nausea—Quinidine—malaria	0.000115	0.000668	CcSEcCtD
Imatinib—Nausea—Quinine—malaria	0.000115	0.000668	CcSEcCtD
Imatinib—Vomiting—Quinidine barbiturate—malaria	0.000111	0.000645	CcSEcCtD
Imatinib—Vomiting—Pentoxifylline—malaria	0.000111	0.000644	CcSEcCtD
Imatinib—Rash—Quinidine barbiturate—malaria	0.00011	0.00064	CcSEcCtD
Imatinib—Dermatitis—Quinidine barbiturate—malaria	0.00011	0.000639	CcSEcCtD
Imatinib—Rash—Pentoxifylline—malaria	0.00011	0.000639	CcSEcCtD
Imatinib—Dermatitis—Pentoxifylline—malaria	0.00011	0.000638	CcSEcCtD
Imatinib—Headache—Quinidine barbiturate—malaria	0.000109	0.000636	CcSEcCtD
Imatinib—Headache—Pentoxifylline—malaria	0.000109	0.000635	CcSEcCtD
Imatinib—ABCB1—liver—malaria	0.000106	0.00107	CbGeAlD
Imatinib—Nausea—Quinidine barbiturate—malaria	0.000104	0.000603	CcSEcCtD
Imatinib—Nausea—Pentoxifylline—malaria	0.000103	0.000602	CcSEcCtD
Imatinib—ABCB1—brain—malaria	8.39e-05	0.000852	CbGeAlD
Imatinib—LCK—Signaling by ERBB4—IL6—malaria	2.13e-05	0.000296	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—G6PD—malaria	2.12e-05	0.000295	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.09e-05	0.000291	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—CD36—malaria	2.09e-05	0.000291	CbGpPWpGaD
Imatinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—IL6—malaria	2.08e-05	0.00029	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—DHODH—malaria	2.08e-05	0.000289	CbGpPWpGaD
Imatinib—KIT—Immune System—IL18—malaria	2.04e-05	0.000284	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—G6PD—malaria	2.04e-05	0.000283	CbGpPWpGaD
Imatinib—LCK—Downstream signal transduction—IL6—malaria	2.03e-05	0.000283	CbGpPWpGaD
Imatinib—LCK—Hemostasis—NOS2—malaria	2.03e-05	0.000283	CbGpPWpGaD
Imatinib—KIT—Immune System—CD40LG—malaria	2.03e-05	0.000282	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR—IL6—malaria	2.02e-05	0.000282	CbGpPWpGaD
Imatinib—ALB—Metabolism—SLC4A1—malaria	2.02e-05	0.000281	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB2—IL6—malaria	2.01e-05	0.00028	CbGpPWpGaD
Imatinib—KIT—Immune System—CD8A—malaria	2.01e-05	0.000279	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—CRP—malaria	2e-05	0.000279	CbGpPWpGaD
Imatinib—LCK—DAP12 signaling—IL6—malaria	2e-05	0.000279	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—HBB—malaria	1.99e-05	0.000277	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—CD4—malaria	1.98e-05	0.000275	CbGpPWpGaD
Imatinib—ALB—Selenium Micronutrient Network—IL6—malaria	1.97e-05	0.000274	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—DHODH—malaria	1.96e-05	0.000273	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—DHODH—malaria	1.94e-05	0.00027	CbGpPWpGaD
Imatinib—KIT—Immune System—HLA-B—malaria	1.93e-05	0.000269	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL18—malaria	1.93e-05	0.000268	CbGpPWpGaD
Imatinib—LCK—Disease—DHFR—malaria	1.92e-05	0.000268	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.92e-05	0.000268	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—TLR4—malaria	1.92e-05	0.000267	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD40LG—malaria	1.92e-05	0.000267	CbGpPWpGaD
Imatinib—CA9—Metabolism—CD36—malaria	1.92e-05	0.000267	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.91e-05	0.000266	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—CD4—malaria	1.9e-05	0.000264	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD8A—malaria	1.9e-05	0.000264	CbGpPWpGaD
Imatinib—ALB—Metabolism—DECR1—malaria	1.9e-05	0.000264	CbGpPWpGaD
Imatinib—KIT—Immune System—CD36—malaria	1.89e-05	0.000263	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—IL6—malaria	1.88e-05	0.000262	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR in disease—IL6—malaria	1.88e-05	0.000262	CbGpPWpGaD
Imatinib—LCK—DAP12 interactions—IL6—malaria	1.88e-05	0.000262	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—IL6—malaria	1.88e-05	0.000261	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—CD4—malaria	1.87e-05	0.000261	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR—IL6—malaria	1.87e-05	0.00026	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR in Cancer—IL6—malaria	1.85e-05	0.000258	CbGpPWpGaD
Imatinib—LCK—Signaling by PDGF—IL6—malaria	1.84e-05	0.000257	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—HLA-B—malaria	1.83e-05	0.000254	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TLR9—malaria	1.82e-05	0.000253	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—SLC4A1—malaria	1.81e-05	0.000252	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—CD4—malaria	1.8e-05	0.00025	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD36—malaria	1.79e-05	0.000249	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—IL6—malaria	1.78e-05	0.000247	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PKLR—malaria	1.77e-05	0.000247	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—ICAM1—malaria	1.77e-05	0.000246	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—SLC4A1—malaria	1.77e-05	0.000246	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.75e-05	0.000244	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL18—malaria	1.74e-05	0.000242	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD40LG—malaria	1.73e-05	0.000241	CbGpPWpGaD
Imatinib—ALB—Metabolism—HBB—malaria	1.71e-05	0.000239	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD8A—malaria	1.71e-05	0.000238	CbGpPWpGaD
Imatinib—KIT—Immune System—CRP—malaria	1.71e-05	0.000237	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—DECR1—malaria	1.7e-05	0.000237	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL18—malaria	1.69e-05	0.000236	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—CD4—malaria	1.69e-05	0.000235	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD40LG—malaria	1.69e-05	0.000235	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—HPGDS—malaria	1.68e-05	0.000234	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—IL2—malaria	1.68e-05	0.000234	CbGpPWpGaD
Imatinib—LCK—NGF signalling via TRKA from the plasma membrane—IL6—malaria	1.67e-05	0.000232	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—HPGDS—malaria	1.67e-05	0.000232	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD8A—malaria	1.67e-05	0.000232	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—HPGDS—malaria	1.67e-05	0.000232	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—SLC4A1—malaria	1.66e-05	0.000232	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—DECR1—malaria	1.66e-05	0.000231	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—DHODH—malaria	1.66e-05	0.000231	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—SLC4A1—malaria	1.65e-05	0.00023	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—HLA-B—malaria	1.65e-05	0.000229	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—CD4—malaria	1.64e-05	0.000229	CbGpPWpGaD
Imatinib—KIT—Immune System—TLR4—malaria	1.64e-05	0.000228	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.63e-05	0.000227	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—CD4—malaria	1.62e-05	0.000226	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—HPGDS—malaria	1.62e-05	0.000225	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CRP—malaria	1.61e-05	0.000225	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD36—malaria	1.61e-05	0.000225	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—IL2—malaria	1.6e-05	0.000223	CbGpPWpGaD
Imatinib—ABL1—Immune System—HLA-B—malaria	1.6e-05	0.000223	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—IL6—malaria	1.6e-05	0.000223	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—G6PD—malaria	1.58e-05	0.00022	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD36—malaria	1.57e-05	0.000219	CbGpPWpGaD
Imatinib—KIT—Immune System—ICAM1—malaria	1.57e-05	0.000218	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—DECR1—malaria	1.57e-05	0.000218	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—DHFR—malaria	1.56e-05	0.000217	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—HPGDS—malaria	1.55e-05	0.000216	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—DECR1—malaria	1.55e-05	0.000216	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—TLR4—malaria	1.55e-05	0.000215	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—DHFR—malaria	1.55e-05	0.000215	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—DHFR—malaria	1.55e-05	0.000215	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—SCARB1—malaria	1.55e-05	0.000215	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—HBB—malaria	1.54e-05	0.000214	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—SCARB1—malaria	1.53e-05	0.000213	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—SCARB1—malaria	1.53e-05	0.000213	CbGpPWpGaD
Imatinib—ALB—Metabolism—PKLR—malaria	1.53e-05	0.000213	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—HBB—malaria	1.5e-05	0.000209	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—DHFR—malaria	1.5e-05	0.000209	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.5e-05	0.000209	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—SCARB1—malaria	1.48e-05	0.000207	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—ICAM1—malaria	1.48e-05	0.000207	CbGpPWpGaD
Imatinib—ALB—Hemostasis—CD36—malaria	1.48e-05	0.000206	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CRP—malaria	1.45e-05	0.000202	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—KDR—malaria	1.44e-05	0.000201	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—DHFR—malaria	1.44e-05	0.000201	CbGpPWpGaD
Imatinib—KIT—Disease—NOS2—malaria	1.44e-05	0.0002	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—SCARB1—malaria	1.43e-05	0.000198	CbGpPWpGaD
Imatinib—ABL1—Immune System—CRP—malaria	1.42e-05	0.000197	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—HBB—malaria	1.42e-05	0.000197	CbGpPWpGaD
Imatinib—ABL1—Axon guidance—IL6—malaria	1.41e-05	0.000196	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SLC4A1—malaria	1.41e-05	0.000196	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—HBB—malaria	1.4e-05	0.000195	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—TLR4—malaria	1.39e-05	0.000194	CbGpPWpGaD
Imatinib—LCK—Immune System—IL18—malaria	1.39e-05	0.000194	CbGpPWpGaD
Imatinib—LCK—Immune System—CD40LG—malaria	1.39e-05	0.000193	CbGpPWpGaD
Imatinib—LCK—Hemostasis—IL2—malaria	1.38e-05	0.000193	CbGpPWpGaD
Imatinib—LCK—Immune System—CD8A—malaria	1.37e-05	0.000191	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PKLR—malaria	1.37e-05	0.000191	CbGpPWpGaD
Imatinib—ALB—Metabolism—G6PD—malaria	1.36e-05	0.00019	CbGpPWpGaD
Imatinib—PDGFRA—Disease—NOS2—malaria	1.36e-05	0.000189	CbGpPWpGaD
Imatinib—ABL1—Immune System—TLR4—malaria	1.36e-05	0.000189	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—CD4—malaria	1.35e-05	0.000188	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—CD36—malaria	1.34e-05	0.000187	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PKLR—malaria	1.34e-05	0.000186	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—ICAM1—malaria	1.34e-05	0.000186	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—DECR1—malaria	1.33e-05	0.000185	CbGpPWpGaD
Imatinib—LCK—Immune System—HLA-B—malaria	1.32e-05	0.000184	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—IL6—malaria	1.31e-05	0.000182	CbGpPWpGaD
Imatinib—ABL1—Immune System—ICAM1—malaria	1.3e-05	0.000181	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CD4—malaria	1.3e-05	0.000181	CbGpPWpGaD
Imatinib—LCK—Immune System—CD36—malaria	1.29e-05	0.00018	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—IL6—malaria	1.28e-05	0.000179	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—DHODH—malaria	1.28e-05	0.000178	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PKLR—malaria	1.26e-05	0.000176	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PKLR—malaria	1.25e-05	0.000174	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—TNF—malaria	1.25e-05	0.000174	CbGpPWpGaD
Imatinib—PDGFRB—Disease—NOS2—malaria	1.22e-05	0.00017	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—G6PD—malaria	1.22e-05	0.00017	CbGpPWpGaD
Imatinib—ALB—Hemostasis—NOS2—malaria	1.21e-05	0.000169	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—CD36—malaria	1.21e-05	0.000168	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—HPGDS—malaria	1.21e-05	0.000168	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—HBB—malaria	1.2e-05	0.000167	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—G6PD—malaria	1.19e-05	0.000166	CbGpPWpGaD
Imatinib—KIT—Immune System—IFNG—malaria	1.19e-05	0.000166	CbGpPWpGaD
Imatinib—LCK—Immune System—CRP—malaria	1.17e-05	0.000163	CbGpPWpGaD
Imatinib—KIT—Immune System—CD4—malaria	1.15e-05	0.00016	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.15e-05	0.00016	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IFNG—malaria	1.13e-05	0.000157	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—G6PD—malaria	1.12e-05	0.000157	CbGpPWpGaD
Imatinib—LCK—Immune System—TLR4—malaria	1.12e-05	0.000156	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—DHFR—malaria	1.12e-05	0.000156	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—G6PD—malaria	1.11e-05	0.000155	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—SCARB1—malaria	1.11e-05	0.000154	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.1e-05	0.000153	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD4—malaria	1.09e-05	0.000152	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SLC4A1—malaria	1.09e-05	0.000152	CbGpPWpGaD
Imatinib—LCK—Immune System—ICAM1—malaria	1.07e-05	0.000149	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—IL6—malaria	1.07e-05	0.000149	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PKLR—malaria	1.07e-05	0.000149	CbGpPWpGaD
Imatinib—KIT—Immune System—IL1B—malaria	1.06e-05	0.000148	CbGpPWpGaD
Imatinib—KIT—Disease—CD4—malaria	1.06e-05	0.000148	CbGpPWpGaD
Imatinib—KIT—Immune System—IL2—malaria	1.06e-05	0.000148	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—KDR—malaria	1.06e-05	0.000147	CbGpPWpGaD
Imatinib—ALB—Metabolism—HPGDS—malaria	1.04e-05	0.000145	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—DECR1—malaria	1.02e-05	0.000142	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IFNG—malaria	1.02e-05	0.000142	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—IL6—malaria	1.01e-05	0.000141	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL1B—malaria	1.01e-05	0.00014	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CD4—malaria	1.01e-05	0.00014	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—IL6—malaria	1.01e-05	0.00014	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL2—malaria	1e-05	0.00014	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—KDR—malaria	1e-05	0.000139	CbGpPWpGaD
Imatinib—ABL1—Immune System—IFNG—malaria	9.91e-06	0.000138	CbGpPWpGaD
Imatinib—LCK—Disease—NOS2—malaria	9.83e-06	0.000137	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD4—malaria	9.83e-06	0.000137	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CD36—malaria	9.7e-06	0.000135	CbGpPWpGaD
Imatinib—ALB—Metabolism—DHFR—malaria	9.64e-06	0.000134	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CD36—malaria	9.61e-06	0.000134	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CD36—malaria	9.6e-06	0.000134	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD4—malaria	9.58e-06	0.000133	CbGpPWpGaD
Imatinib—ALB—Metabolism—SCARB1—malaria	9.54e-06	0.000133	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—G6PD—malaria	9.53e-06	0.000133	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	9.4e-06	0.000131	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL2—malaria	9.35e-06	0.00013	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—HPGDS—malaria	9.33e-06	0.00013	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CD36—malaria	9.32e-06	0.00013	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—HBB—malaria	9.26e-06	0.000129	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—IL6—malaria	9.12e-06	0.000127	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—HPGDS—malaria	9.1e-06	0.000127	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL1B—malaria	9.07e-06	0.000126	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CD4—malaria	9.07e-06	0.000126	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL2—malaria	9.04e-06	0.000126	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—KDR—malaria	9.02e-06	0.000126	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CD36—malaria	8.95e-06	0.000125	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—IL6—malaria	8.89e-06	0.000124	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL1B—malaria	8.84e-06	0.000123	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL2—malaria	8.81e-06	0.000123	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—DHFR—malaria	8.65e-06	0.00012	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—HPGDS—malaria	8.58e-06	0.000119	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—SCARB1—malaria	8.56e-06	0.000119	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—HPGDS—malaria	8.5e-06	0.000118	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—DHFR—malaria	8.44e-06	0.000118	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—SCARB1—malaria	8.36e-06	0.000116	CbGpPWpGaD
Imatinib—ALB—Hemostasis—IL2—malaria	8.27e-06	0.000115	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PKLR—malaria	8.25e-06	0.000115	CbGpPWpGaD
Imatinib—LCK—Immune System—IFNG—malaria	8.16e-06	0.000114	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—DHFR—malaria	7.96e-06	0.000111	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—DHFR—malaria	7.89e-06	0.00011	CbGpPWpGaD
Imatinib—LCK—Immune System—CD4—malaria	7.89e-06	0.00011	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—SCARB1—malaria	7.87e-06	0.00011	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—SCARB1—malaria	7.81e-06	0.000109	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—G6PD—malaria	7.35e-06	0.000102	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—IL6—malaria	7.32e-06	0.000102	CbGpPWpGaD
Imatinib—LCK—Immune System—IL1B—malaria	7.28e-06	0.000101	CbGpPWpGaD
Imatinib—LCK—Disease—CD4—malaria	7.28e-06	0.000101	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—HPGDS—malaria	7.27e-06	0.000101	CbGpPWpGaD
Imatinib—LCK—Immune System—IL2—malaria	7.26e-06	0.000101	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—KDR—malaria	7.24e-06	0.000101	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CD36—malaria	6.95e-06	9.67e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL2—malaria	6.85e-06	9.54e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—DHFR—malaria	6.74e-06	9.38e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SCARB1—malaria	6.67e-06	9.29e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL2—malaria	6.49e-06	9.03e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IL6—malaria	6.23e-06	8.67e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CD36—malaria	5.99e-06	8.33e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL6—malaria	5.9e-06	8.21e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL2—malaria	5.85e-06	8.14e-05	CbGpPWpGaD
Imatinib—KIT—Disease—IL6—malaria	5.75e-06	8.01e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—HPGDS—malaria	5.61e-06	7.81e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL6—malaria	5.5e-06	7.65e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—IL6—malaria	5.45e-06	7.58e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CD36—malaria	5.37e-06	7.48e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL6—malaria	5.31e-06	7.4e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CD36—malaria	5.24e-06	7.3e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—DHFR—malaria	5.2e-06	7.24e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL6—malaria	5.18e-06	7.21e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SCARB1—malaria	5.15e-06	7.17e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CD36—malaria	4.94e-06	6.88e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—IL6—malaria	4.91e-06	6.83e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CD36—malaria	4.9e-06	6.82e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL2—malaria	4.69e-06	6.53e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL6—malaria	4.26e-06	5.94e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CD36—malaria	4.19e-06	5.83e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL6—malaria	4.03e-06	5.61e-05	CbGpPWpGaD
Imatinib—LCK—Disease—IL6—malaria	3.94e-06	5.48e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL6—malaria	3.81e-06	5.31e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL6—malaria	3.44e-06	4.78e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CD36—malaria	3.23e-06	4.5e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL6—malaria	2.76e-06	3.84e-05	CbGpPWpGaD
